bepridil has been researched along with olmesartan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Fukaya, H; Hirasawa, S; Izumi, T; Kiryu, M; Masaki, Y; Moriguchi, M; Niwano, H; Niwano, S; Sato, D | 1 |
2 other study(ies) available for bepridil and olmesartan
Article | Year |
---|---|
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Combined effects of up- and downstream therapies on atrial fibrillation in a canine rapid stimulation model.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Disease Models, Animal; Dogs; Down-Regulation; Drug Therapy, Combination; Heart Conduction System; Imidazoles; Tetrazoles; Up-Regulation | 2012 |